Related Experiment Video
Updated: Jan 11, 2026
01:22
Bone Marrow Sampling and Transplants
846
Phenotypic plasticity and the epigenetics of human disease
1Department of Medicine and Center for Epigenetics, Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, Maryland 21205, USA. afeinberg@jhu.edu
Nature
|May 25, 2007
Summary
Epigenetic changes influence human development and disease by affecting cellular plasticity. Understanding these epigenetic mechanisms offers new avenues for disease risk stratification and targeted therapies.
Area of Science:
- Epigenetics and Molecular Biology
- Developmental Biology
- Disease Mechanisms
Background:
- Epigenetic modifications play crucial roles in both normal development and the pathogenesis of various human diseases.
- A central concept in disease epigenetics is the impairment of phenotypic plasticity, which is the capacity of cells to alter their behavior in response to environmental signals.
Purpose of the Study:
- To propose a unifying model for the role of epigenetic defects in human diseases.
- To explore the implications of epigenetic dysregulation in developmental disorders, cancer, and common late-onset diseases.
- To highlight the potential of epigenetic research for developing novel therapeutic strategies.
Main Methods:
- This study presents a conceptual model based on current understanding of epigenetics and disease.
- It integrates findings from developmental biology, cancer research, and studies on common complex diseases.
- The model synthesizes the interplay between the epigenome, genome, and environmental factors.
Main Results:
- Hereditary disorders of the epigenetic machinery are linked to developmental defects.
- Epigenetics in cancer involves the disruption of crucial stem-cell programs.
- Common late-onset diseases arise from complex interactions among the epigenome, genome, and environment.
Conclusions:
- Epigenetic dysregulation is a fundamental aspect of numerous human diseases.
- A deeper understanding of epigenetic-disease links can enable precise disease risk stratification.
- Targeted epigenetic therapies hold promise for future clinical interventions.